These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8091373)

  • 21. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J
    Encephale; 1993; 19(1):17-21. PubMed ID: 8275889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
    Sivrioglu EY; Kirli S; Sipahioglu D; Gursoy B; Sarandöl E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1493-9. PubMed ID: 17688987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Controlled comparison of nalorphine with haloperidol in acute psychoses of the schizophrenic group ].
    Svestka J; Náhunek K; Cesková E; Rysánek R
    Cesk Psychiatr; 1982 Jun; 78(3):159-66. PubMed ID: 6749311
    [No Abstract]   [Full Text] [Related]  

  • 25. Review of haloperidol blood level and clinical response: looking through the window.
    Volavka J; Cooper TB
    J Clin Psychopharmacol; 1987 Feb; 7(1):25-30. PubMed ID: 3546403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haloperidol plasma/red blood cell ratios and clinical efficacy.
    Neborsky R; Janowsky DS; Perel J; Munson E; Depry D
    Psychopharmacol Bull; 1982 Oct; 18(4):17-20. PubMed ID: 7156285
    [No Abstract]   [Full Text] [Related]  

  • 27. Elevation of choline and glycine in red blood cells of psychiatric patients due to lithium treatment.
    Shea PA; Small JG; Hendrie HC
    Biol Psychiatry; 1981 Sep; 16(9):825-30. PubMed ID: 7295842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol reduction can be assayed in human red blood cells.
    Inaba T; Kalow W; Someya T; Takahashi S; Cheung SW; Tang SW
    Can J Physiol Pharmacol; 1989 Nov; 67(11):1468-9. PubMed ID: 2697459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma haloperidol levels and clinical response: confounding variables.
    Mavroidis ML; Garver DL; Kanter DR; Hirschowitz J
    Psychopharmacol Bull; 1985; 21(1):62-5. PubMed ID: 3983340
    [No Abstract]   [Full Text] [Related]  

  • 30. [Plasma monitoring of haloperidol. Correlation with clinical efficacy and plasma prolactin levels].
    Giraud-Serio J; Goyot C; Debray Q; Plaisant O; Grenier J; Pélicier Y
    Ann Med Psychol (Paris); 1985 Nov; 143(9):900-11. PubMed ID: 3834819
    [No Abstract]   [Full Text] [Related]  

  • 31. CYP3A4 activity and haloperidol effects in alcohol addicts.
    Zastrozhin MS; Smirnov VV; Sychev DA; Savchenko LM; Bryun EA; Matis OA
    Int J Risk Saf Med; 2015; 27 Suppl 1():S23-4. PubMed ID: 26639694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of pharmacokinetic data during the treatment of psychoses with haloperidol].
    Zarifian E; Cottereau MJ; Cuche H; Lôo H; Deniker P
    Encephale; 1979; 5(3):197-203. PubMed ID: 487991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol.
    Eyles DW; Whiteford HA; Stedman TJ; Pond SM
    Psychopharmacology (Berl); 1992; 106(2):268-74. PubMed ID: 1549652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium and haloperidol.
    Nemes ZC; Volavka J; Cooper TB; O'Donnell J; Jaeger J
    Biol Psychiatry; 1986 May; 21(5-6):568-9. PubMed ID: 3697447
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma haloperidol levels and clinical response in acute schizophrenia.
    Extein I; Augusthy KA; Gold MS; Pottash AL; Martin D; Potter WZ
    Psychopharmacol Bull; 1982 Oct; 18(4):156-8. PubMed ID: 7156281
    [No Abstract]   [Full Text] [Related]  

  • 36. [Haloperidol in the treatment of psychotic disorders in old age].
    Kobrzyńska E; Chachaj L
    Psychiatr Pol; 1982; 16(1-2):13-7. PubMed ID: 7146202
    [No Abstract]   [Full Text] [Related]  

  • 37. Enlargement of cerebral third ventricle in psychotic patients with delayed response to neuroleptics.
    Kaplan MJ; Lazoff M; Kelly K; Lukin R; Garver DL
    Biol Psychiatry; 1990 Jan; 27(2):205-14. PubMed ID: 2294982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red blood cell/plasma haloperidol ratios and antipsychotic efficacy.
    Neborsky RJ; Janowsky DS; Perel JM
    Psychiatry Res; 1982 Feb; 6(1):123-4. PubMed ID: 6949166
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical evaluation of haloperidol in geriatric patients.
    Tobin JM; Brousseau ER; Lorenz AA
    Geriatrics; 1970 Jun; 25(6):119-22. PubMed ID: 4915764
    [No Abstract]   [Full Text] [Related]  

  • 40. Haloperidol in controlling the symptoms of acute psychoses. I. A preliminary investigation.
    Goldstein BJ
    Curr Ther Res Clin Exp; 1966 May; 8(5):232-5. PubMed ID: 4956548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.